- Galan Lithium's (GLN) testwork on lithium chloride concentrate from its Hombre Muerto West Project is nearing completion
- Last year, Chile-based lithium experts and universities were engaged to conduct lab testing of brine sourced from Galan's Argentinian project
- Essentially, Galan is testing whether a concentrate with up to 4.8 per cent lithium or, 25.6 per cent lithium carbonate equivalent, can be obtained
- So far, results have indicated that brine from Galan's lithium project is highly competitive for the production of battery-grade lithium carbonate
- Testing continues and final lab results are expected by the end of this month
- Company shares are up 3.19 per cent and trading at 48.5 cents
Galan Lithium (GLN) has announced chemical laboratory work for its Hombre Muerto West (HMW) Project is 85 per cent complete.
Towards the end of last year, Ad-Infinitum and Chile-based universities began testing lithium chloride concentrate sourced from the HMW Project in Argentina.
A preliminary predictive model was completed in August, which showed a concentrate with up to 4.8 per cent lithium or, 25.6 per cent lithium carbonate equivalent, can be obtained. So, this testing is aiming to solidify what the predictive modelling outlined.
So far, lab results have shown strong correlations with the brine evaporation model predictions — outlining brine from the HMW Project as "more than competitive" for the production of battery-grade lithium carbonate.
"We continue to advance our HMW lab testing with interim results showing great progress despite the COVID-19 challenges in South America," Managing Director JP Vargas de la Vega said.
"Last year we took a 20 cubic metre sample of brine to Chile with the objective of continuing our testing and to provide enough samples to assay several evaporation trains to look beyond our initial preliminary economic assessment and scoping study plan," JP added.
Unfortunately, lab testing has faced some delays, such as university closures and limited lab testing capacity due to COVID-19 restrictions. Nevertheless, testing continues and final lab results are expected by the end of this month.
Company shares are up 3.19 per cent and trading at 48.5 cents at 2:02 pm AEDT.